Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Lipopharma Therapeutics S.L.
DescriptionSynthetic polyunsaturated fatty acid derivative
Molecular Target Cyclooxygenase-1 (COX-1) ; Cyclooxygenase-2 (COX-2)
Mechanism of ActionCyclooxygenase (COX) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationInflammatory disease
Indication DetailsTreat inflammatory disease
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today